United States · FDA National Drug Code directory
Ticagrelor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-241_ef3c94fb-69c7-4649-874d-bb4bedc1152d
- Product NDC
- 46708-241
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ticagrelor
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250501
- Source listing expiry
- 20261231
Source-listed ingredients
- TICAGRELOR — 90 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (46708-241-30) · 46708-241-30
- 100 TABLET, FILM COATED in 1 BOTTLE (46708-241-31) · 46708-241-31
- 60 TABLET, FILM COATED in 1 BOTTLE (46708-241-60) · 46708-241-60
- 1000 TABLET, FILM COATED in 1 BOTTLE (46708-241-91) · 46708-241-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →